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Summary 
The receptors for IL-3, GM-CSF, and IL-5 share a com- 
mon 5 subunit (5c), and mice have an additional IL-3 
5 subunit (5~). We have independently generated mice 
carrying null mutations of each molecule. f3c mutant 
bone marrow showed no response to GM-CSF or IL-5, 
whereas IL-3 stimulation of f3c or fiIw mutant bone mar- 
row was normal. fit mutant mice showed lung pathoi- 
ogy consisting of lymphocytic infiltration and areas 
resembling alveolar protelnosis, and also exhibited 
low basal numbers of eoslnophils. Infection of 5c mu- 
tant mice by Nippostrongyius brasiliensis resulted in 
the absence of blood and lung eoslnophllla. Animals 
repopulated with pc mutant bone marrow cells showed 
slower leukocyte recovery and reduced eosinophil 
numbers. These data define the role of 5c in vivo, and 
show a phenotype that is likely to be the cumulative 
effect of loss of GM-CSF and IL-5 stimulation. I 
Introduction 
Although interleukin3 (IL-3), granulocyte-macrophage 
colony-stimulating factor (GM-CSF), and IL-5 show no sig- 
nificant amino acid sequence homology with each other, 
they exhibit a number of similarities. IL-3 stimulates the 
development of various lineages of hematopoietic cells, 
at least in colony assays, by interacting with immature 
multipotential hematopoietic progenitors as well as with 
lineage-committed progenitors, and thus wasoriginally re- 
ferred to as multicolony-stimulating factor (multi-CSF) 
(Arai et al., 1990). GM-CSF was originally defined as a 
factor that stimulates colony formation of granulocytes and 
macrophages, and has subsequently been shown to share 
many of the properties of IL-3 stimulation of cells (Metcalf, 
1991). While IL-5 was cloned as a B cell differentiation 
factor in mice (Kinashi et al., 1986) it appears to have a 
role in the development of eosinophils in both mice and 
humans, an activity shared by IL-3 and GM-CSF (Takatsu 
et al., 1968). These three cytokines are closely linked on 
human chromosome 5 and mouse chromosome 11, and 
are produced by activated T cells and mast cells (Arai et 
al., 1990). They induce protein phosphorylation of similar 
proteins (Isfort and Ihle, 1990; Kanakura et al., 1990) and 
compete with each other in binding to their high affinity 
receptors (Lopez et al., 1990; Taketazu et al., 1991; Lopez 
et al., 1991). Curiously, this cross-competition was ob- 
sewed only in human hematopoietic cells, but not in 
mouse cells. 
Molecular cloning of the receptor subunits has ex- 
plained at least some of these observations. The high affin- 
ity receptors for human IL-3, GM-CSF, and IL-5 are com- 
posed of two subunits, a and 8 (Hayashida et al., 1990; 
Kitamura et al., 1991; Tavernier et al., 1991). The a sub- 
units are specific for each cytokine and bind their ligand 
with low affinity. The human has only one type of 8 subunit 
(PC), which has no binding capacity by itself but forms 
high affinity receptors for IL-3, GM-CSF, and IL-5 with their 
respective a subunits. 
In contrast with the human, the mouse has two homolo- 
gous 8 subunits, PC and pIw, which were previously termed 
AIC2B and AICPA, respectively (Itoh et al., 1990; Gorman 
et al., 1990). They are 56% identical to the human pc. 
Like the human PC, the mouse 8c is the common 8 subunit 
for mouse IL-3, GM-CSF, and IL-5 receptors. Although f3113 
has an extensive sequence homology with mouse PC (91% 
identical at the amino acid level), pIL3 does not form a high 
affinity receptor with the mouse IL-5 or mouse GM-CSF 
a receptors. t&, originally cloned as a mouse IL-3-binding 
protein, binds mouse IL-3 with low affinity. When trans- 
fected into cells, both pc and P,L~ interact equally well with 
the mouse IL-3 a subunit in the presence of IL-3 to form 
high affinity IL-3 receptors and to transmit a proliferation 
signal. (Hara and Miyajima, 1992). The genes encoding 
these two 8 subunits are closely linked on mouse chromo- 
some 15, and their exon-intron structures are almost iden- 
tical (Gorman et al., 1992). Thus, they are likely products 
of a gene duplication event after the divergence of mouse 
and human. Why the mouse has two 6 subunits remains 
to be explained. 
As many studies have examined the potential role of 
IL-3, GM-CSF, and IL-5 in hematopoietic development, 
as well as potential roles in infectious disease states and 
hematopoietic crises (Antman et al., 1988; Nemunaitis et 
al., 1988; Coff man et al., 1989), we reasoned that targeted 
disruption of the PC and OIL3 receptor chain genes in the 
mouse would allow us to evaluate collectivelythe functions 
of the cytokines in vivo. In this report, we describe the 
production and characterization of mutant mice for 6c and 
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Figure 1. Targeting Strategy of PC and plU Gene6 
(A) (a) Genomic 6tructure and reStriction maps of wild-type DC and pIU genes. The upper part of the central horizontal line is for pc and the lower 
part for pIL9. B indicate6 BamHl sites. The closed squares show the exons. (b) Targeting vectors used to disrupt f3c and t&,. The neo’ gene was 
inserted into exon 4. TK indicates herpes simplex virus thymidine kinase. (c) Predicted structure of the disrupted alleles. The upper part shows 
pc and the lower part plU. Probe D was used for routine screening by Southern blot analysis. 
(8) Southern blot analysis of wild-type (+/+), heterozygous (+/-), homozygous (-I-) l3c mutant mice. Tail DNA was digested with BamHl and 
hybridized with probe D. Note that the band from pc gene disappeared in homozygous mutant mice, but the band from SIU remained intact. 
(C) Southern blot analysis of wild-type (+/+), heterozygous (+/-), homozygous (-I-) f3ru mutant mice. Tail DNA was digested with SamHI and 
hybridized with probe D. Note that the band from pIU gene disappeared in homozygous mutant mice, but the band from SC remained intact. 
pIw. We examined intrinsic pathology of the mutants, cell 
lineage development in the mutant animals and in normal 
irradiated recipient animals receiving mutant bone mar- 
row, and the response of the mutant animals to parasitic 
infections. 
Results 
Generation of Mice Homozygous for pc 
and plu Mutations 
The genes encoding pc and pIu were independently dis- 
rupted in E14.1 embryonic stem cells using conventional 
gene targeting techniques. A map of the PC and bIL3 locus 
and their representative gene-targeting vectors is shown 
in Figure 1A. In brief, the neomycin resistant gene (neo’) 
was inserted into exon 4, which encodes the third and 
fourth cystein residues in the first repeat of the conserved 
motif of cytokine receptors. These constructs generate 
truncated molecules by introducing a stop codon and 
poly(A) addition signal. Alternative splicing from exon 3 to 
5 would cause aframeshift mutation. A targeted disruption 
of the pc gene yielded a 2.5 kb BamHl fragment as op 
posed to a50 kb wild-type fragment. 91” disruption yielded 
a 2.5 kb fragment as opposed to an 11.2 kb wild-type frag- 
ment (Figures 1 Band 1C). Although the coding sequence 
of these two genes is 95% homologous, no evidence for 
a j3c construct recombining at the pIL3 locus (or vice versa) 
was observed. Following injection of the homologous re- 
combinants into blastocysts, we obtained chimeras able 
to transmit the mutations through the germline from two 
independent clones, both for j3c and BIw. Heterozygous 
mice were intercrossed to obtain mice homozygous for 
the mutations (Figure 1 B and 1 C). Normal Mendelian seg- 
regation of the mutations was observed. Both j3c and pIL3 
mutants remained clinically healthy for 7 months of obser- 
vation, and were fertile. The results described below were 
consistent in the two lines of mice, both for j3c and pIL3 
mutations. 
To demonstrate that f3c was disrupted, bone marrow 
cells from j3c-deficient mice were stained with anti-gc-spe- 
cific antibody (Figure 2A). As expected, DC was not de- 
tected. Staining of these same bone marrow cells with 
anti-IL-specific antibody showed that expression of pIL3 
was intact (data not shown). In the case of j&deficient 
mice, the results from FACS analysis were equivocal due 
to the weak background staining of antig,u+pecific anti- 
body. However, immunoblot analysis of bone marrow- 
derived mast cells showed no expression of 5,” protein 
(Figure 28). FACS analysis showed that expression of bc 
was intact in BIw mutant mice (data not shown). 
Response of Mutant Cells to Cytokines 
To investigate the response of PC- or PIw-deficient cells 
to various cytokines, methyl cellulose colony-forming unit 
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Figure 2. FACS Analysis and Immunoprecipi- 
tation of 6c and 6rLl 
(A) FACS analysis of bone marrow cells from 
wild-type (+/+) and @deficient (-I-) mice. 
Bone marrow cells were stained with either 
anti-gospecific antibody or isotype control. 
(B) lmmunoblot analysis of bone marrow- 
derived mast cells. Bone marrow-derived mast 
cells from wild-type (+/+) or &+deficient mice 
(-I-) were lysed and immunoprecipitated with 
anti-f&-specific antibody or isotyps control, and 
blotted with anti-&-specific antibody. MC/9 
cells were used as positive control. 
(CFU) assays were performed using bone marrow cells 
(Table 1). Pcdeficient cells did not respond to GM-CSF 
or IL-5 indicating that both GM-CSF and IL-5 receptors 
were disrupted functionally. However, DC-deficient cells 
did respond to IL-3 or IL-3 plus erythropoietin (EPO) nor- 
mally. Colony types in IL-3 or IL-3 plus EPO plates were 
enumerated and no variations were seen, which indicates 
that PIL3 can transmit the IL-3 signal in the complete ab- 
sence of PC. Eosinophil colonies were also detected in IL-3 
or IL-3 plus EPO plates and were morphologically normal, 
suggesting that eosinophils were generated in vitro only 
by IL-3 in the absence of IL-5 
In contrast, PILJ-deficient cells responded almost nor- 
mally to IL-3, GM-CSF, and IL-5 This result showed that 
f3c and BIB were redundant in terms of IL-3 stimulation, 
as well as confirming that pIL3 was not involved in the GM- 
CSF or IL-5 receptor system. 
Normal multilineage colonies were formed from both pc 
and pIL3 mutant cells if a stimulus that is unrelated to the 
f3c and pIL3 receptors, such as stem cell factor (SW) was 
used. 
Bone marrow cells were cultured in liquid media con- 
taining 11-3. Both fk- and (&deficient cells proliferated 
normally, and mast cells were generated after 35 days of 
culture. These mast cells were not different from wild-type 
cells in terms of proliferation in the presence of IL-3 and 
Table 1. Colony-Forming Unit Assay from Mutant Bone Marrow 
Control 6c Mutant Control’ BIo Mutant 
GM-CSF 64.33 (12.56) 0.00 (0.00) 71.33 (7.51) 71 .oo (7.94) 
IL-5 6.00 (2.65) 0.00 (0.00) 10.00 (2.00) 9.00 (3.00) 
IL-3 89.33 (12.56) 102.35 (16.90) 79.67 (12.01) 65.33 (6.66) 
IL-3 plus EPO 102.67 (11.93) 93.00 (7.00) 91.00 (1.73) 90.67 (4.51) 
SCF plus IL-6 plus EPO 65.67 (1.15) 66.33 (2.69) 56.00 (4.36) 67.00 (6.06) 
EPO 1.67 (0.56) 0.67 (1.15) 4.33 (2.52) 4.67 (0.56) 
Methyl cellulose colony assay to bone marrow cells from the mutant mice. Cells (2 x IO’) were plated in each plate containing the cytokines 
indicated, and the total number of colonies was counted. Cells (4 x IO’) were plated for IL-5 stimulation. Each type of stimulation was performed 
in triplicate and the mean ( f standard deviation) is presented. 
a The experiments for 6c and 6ro were performed independently, using their respective normal littermate controls. Three independent experiments 
were performed for both 6c and BIL3, and consistent results were obtained. 
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Figure 4. Eosinophils in DC-Deficient Mice 
The percentage of eosinophils in the peripheral blood was examined 
over a 10 week period. The data represent the mean ( f standard 
deviation)of eight mice in each group. Control, open circles; PC mutant, 
closed circles. 
the staining patterns of granules (Wright-Giemsa, alcian 
blue, and safranin). There was no difference in connective 
tissue-type mast cells recovered from peritoneal washes, 
with respect to their frequency, proliferation in IL-3 plus 
11-4, or staining patterns (data not shown). 
HIstological Characterization of Pulmonary Disease 
in flc-Deficient Mice 
Pathologic examination of @deficient mice showed 
anomalous lung development, but no abnormalities were 
seen in f&-deficient mice. Two seemingly separate find- 
ings were consistent in all @-deficient animals: a focal 
but scattered intraalveolar proteinous substance and peri- 
bronchovascular lymphocytic infiltration of the tissue. 
Lungs from pc mutant mice were examined at 10 and 27 
weeks of age to follow potential progression of the pa- 
thology. 
The alveolar spaces of all f3c mutants contained focal but 
scattered eosinophilic proteinous material with necrotic 
cellular debris and macrophages (Figure 38) in clear con- 
trast with control mice (Figure 3A). This pathology was 
often found beneath the pleura. Few inflammatory cells, 
such as neutrophils and lymphocytes, were obsenred di- 
rectly in the focal lesions, suggesting that this disorder 
was not a secondary response to infections. In support of 
this, extensive pathogen screening revealed no bacterial, 
fungal, or viral infections in these animals (data not 
shown). Both lo- and 27-week-old mice showed intraal- 
veolar material and this material was periodic acid Schiffs 
reaction (PAS) positive. In theolder mice, the PAS-positive 
material was acellular (Figure 3C, inset). These findings 
resembled alveolar proteinosis (Rosen et al., 1959). 
A second prominent finding in the lungs of PC mutants 
was peribronchovascular lymphocytic infiltration, and this 
infiltration was similar in mutant mice at both 10 and 27 
weeks of age (Figure 3B). The infiltration was also detected 
in areas where no proteinosis was present, indicating that 
the infiltration was a primary event resulting from the pc 
mutation and not necessarily secondary to the proteinosis. 
In support of this, the infiltration was also seen in heterozy- 
gous mutant mice, to a milder extent and with no pro- 
teinosis (data not shown). 
Additionally, there were many foamy macrophages in 
the alveoli of the 27-week-old mice (Figure 3C). In some 
cases, these cells contained PAS-positive material, sug- 
gesting that they could not degrade the ingested material 
(data not shown). 
The findings of alveolar proteinosis-like disease and the 
lymphocytic infiltration are similar to the phenotype of GM- 
CSF-deficient mice (Dranoff et al., 1994; Stanley et al., 
1994). 
@Deficient Mice Had Impaired Eosinophil 
Development and Lacked Eosinophil 
Responses to Parasites 
Examination of peripheral blood and bone marrow cells 
from Bc- and &deficient mice revealed that the pc mu- 
tants lacked normal numbers of eosinophils. Total periph- 
eral leukocyte counts, differential counts (except for eosin- 
ophils), hemoglobin, and platelet counts were normal in 
both mutant mice. Bone marrow, spleen, and peritoneal 
cellularities were also normal (data not shown). 
The percentage of eosinophils in the peripheral blood 
was examined from pc-deficient mice over a 10 week pe- 
riod and was significantly lower than that of wild-type mice 
(Figure 4). The few eosinophils found in 3c mutants were 
morphologically normal. 
Challenge to the immune system by parasitic organ- 
isms, such as Nippostrongylus brasiliensis, is character- 
ized by marked eosinophilia and immunoglobulin E (IgE) 
production with well-defined kinetics (Urban et al., 1992). 
N. brasiliensis typically induces blood eosinophilia detect- 
able at 7 days postinfection and subsiding by 21 days, as 
well as inducing lung granulomatous lesions composed 
of eosinophils, granulocytes, monocytes, and other cell 
types. As the @deficient mice exhibited low circulating 
numbers of eosinophils, we examined eosinophil re- 
sponse to N. brasiliensis in f3c and pw mutant mice. Ani- 
mals were infected with 500 third-stage N. brasiliensis lar- 
vae and bled over a 3 week period to determine peripheral 
eosinophil counts. No eosinophil response was detected 
in the peripheral blood of pc mutant mice, whereas the 
response of PILs-deficient mice was not significantly differ- 
ent from that of the wild-type mice (Figure 5A). These data 
indicate that f3c is not only essential for normal develop- 
ment of eosinophils but also for mounting a strong eosino- 
phil response. The increase in serum IgE levels, another 
characteristic response to parasites, was similar in all 
three groups of animals (Figure 5B). 
Lung tissue from both control and PC mutant mice in- 
fected with N. brasiliensis was examined. The lungs from 
control mice showed peribronchoalveolar lymphocytic in- 
filtration and scattered granulomatous lesions with promi- 
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Figure 5. Response to Parasite Challenge 
(A) Mice (11 weeks old) were infected with 500 third-stage N. bra- 
siliensis larvae, and the absolute number of peripheral eosinophils 
was counted. The data represent the mean ( f standard deviation) of 
5 mice in each group. 
(6) Serum IgE before and after the challenge of N. brasiliensis. In 
each group, 7 mice were analyzed from the same experiment as Fig- 
ure 5A. 
nent eosinophil infiltration and macrophages 14 days after 
infection (Figure 6A). However, the lungs from PC mutants 
showed severe edematous fluid accumulation and diffuse 
infiltration of mononuclear cells and neutrophils not only 
in peribronchial areas but also in most of the pulmonary 
airspace. There were no granulomatous lesions in the 
specimens and no eosinophils were detected (Figure 6B). 
The lungs from control mice showed only remnant infec- 
tious lesions, where some scattered mononuclear cells 
were seen mixed with fibrous remnant tissue, 21 days after 
infection (Figure 6C). In contrast, there seemed to be a 
possible prolongation of inflammatory process in the lung 
tissue from pc mutants. Interestingly, some small granulo- 
matous lesions were formed and they contained a small 
number of eosinophils (Figure 6D). These results sug- 
gested that the other signals, possibly IL-3 interacting 
through the BIN receptor, recruited eosinophils to a much 
lesser extent and at much slower kinetics. 
Normal Irradiated Animals that Received Bc-Deficient 
Bone Marrow Cells Showed Slower Kinetics of 
Leukocyte Repopulation and Lacked Normal 
Eosinophll Development 
To evaluate further the intrinsic nature of the cellular de- 
fects in pc mutant animals, PC-deficient bone marrow was 
transferred into normal but irradiated recipient animals. 
To facilitate this transfer, we used 129/J (Ly5.1) x C57BU 
SJL (Ly5.2) Fl recipient animals. The use of the Fl recipi- 
ent animals allowed us to overcome graft-versus-host re- 
action from the 129 x C57BU6 F2mutant animals(Ly5.1), 
and to mark genetically the donor versus recipient repopu- 
lation Bone marrow from three f3c mutant animals was 
separately transferred into between 5 and 9 irradiated re- 
cipient animals. All recipient animals survived the hemato- 
poietic crisis and repopulation and, to date, have shown 
no signs of graft-versus-host reaction. FACS analysis of 
recipient animals confirmed greater than 90% repopula- 
tion of donor cells (data not shown). The kinetics of leuko- 
cyte repopulation are shown in Figure 7A. pc mutant bone 
marrow consistently showed slightly slower repopulation 
in all recipient animals from multiple independent donors. 
However, spleen colony-forming unit (CFU-S) assays were 
performed, using control or DC mutant donor bone marrow. 
Day 8 and day 12 CFU-S were similar for both groups of 
animals (data not shown). These data indicate that the 
earliest donor-derived repopulating cells in the spleen are 
not dependent on signals through f3c, but that the contin- 
ued and efficient repopulation of cells to normal numbers 
in the peripheral blood is enhanced by stimulation through 
the f3c receptor. As most repopulating cells were shown 
to be donor derived, differential smears were then evalu- 
ated to distinguish cell types during leukocyte recovery. 
Figure 78 shows that, by 5 weeks posttransfer, recipient 
animals had low recovery of eosinophils, similar to the 
reduced number of eosinophils in unmanipulated PC mu- 
tants. At 12 weeks posttransfer, peripheral donor-derived 
cells (Ly5.1+, Ly5.2-) were purified from any residual recipi- 
ent cells (Ly5.1+, Ly5.2+) by cell sorting and the percentage 
of eosinophils in cytospun preparations were counted. The 
donor-derived eosinophil percentage in the animals 
grafted with pc mutant cells was 0.20% -+ 0.20% (n = 
3), significantly lower than that in the controls ( 2.23% f 
0.55%, n = 3). Thus, the lack of proper eosinophil devel- 
opment is clearly an autonomous defect for this cell lin- 
eage, owing to the absence of functional PC. Mutant bone 
marrow recipient animals have shown no obvious signs 
of pulmonary disease. This may be due to ineff icient repop- 
ulation of hematopoietic lineages in the lung, or in contrast, 
may be due to other nonhematopoietic cell types in the 
lung that may be involved in the development of the pulmo- 
nary disease state. 
Discussion 
The receptors for IL-3, GM-CSF, and IL-5 share a common 
p subunit (PC), which explains many similar biological ac- 
tivities common to the three ligands. Mice have an addi- 
tional B chain that is specific for IL-3 (BIw), but is not present 
in humans. To evaluate the roles of f3c and BIw in vivo, and 
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the potential redundancies between them, we generated 
mice carrying null mutations for either of the two subunits. 
The genes for 8c and pIL3 reside on mouse chromosome 
15 and are within 250 kb of each other (Gorman et al., 
1992). The coding sequence of the two genes is 95% ho- 
mologous, and restriction mapping indicates extensive ho- 
mology in intron sequence as well. In this regard, it is 
interesting that neither targeting vector recombined with 
the other homologous gene, implying that strict conserva- 
tion of sequence is necessary for optimal homologous re- 
combination frequencies. 
8c mutant cells were examined by methyl cellulose CFU 
assays and showed that GM-CSF and IL-5 receptors were 
functionally disrupted, reconfirming that 8c is the common 
and the only 8 chain for both receptors. In contrast, the 
number and the types of colonies generated from 8c mu- 
tant cells by IL-3 (functioning through the PIL3 receptor sub- 
unit) were not significantly different from those of the con- 
trols, indicating that 8,~ could transmit the IL-3 signal in 
the absence of 8c. We also showed that f&deficient cells 
responded almost normallyto IL-3. These results indicated 
that pc and PI13 were redundant in terms of IL-3 stimulation. 
This redundancy was also confirmed in the proliferation of 
bone marrow cells in liquid culture, bone marrow-derived 
mast cells and connective tissue-type mast cells. As 8c 
and pIL3 share only IL-3 as a ligand but not GM-CSF or 
IL-5, the phenotypes we described in 8cdeficient animals 
are likely to be the cumulative effects of these two latter 
cytokines. The correlation of these defects to GM-CSF 
and IL-5 indicate that other uncharacterized cytokines 
probably do not interact through the PC receptor. Con- 
versely, if such cytokines do exist and interact through the 
pc receptor, the associated phenotype of that individual 
cytokine must be minimal. 
pc mutant mice exhibited lung abnormalities, including 
proteinous material in the alveolar spaces and peribron- 
chovascular lymphocytic infiltration. Portions of this pa- 
thology resembled alveolar proteinosis. This lung disorder 
typically involves surfactant accumulation in alveoli and 
can also be influenced by infectious agents in the lung 
(Rosen et al., 1958). These findings were probably attribut- 
able to the loss of activity of GM-CSF, because this pheno- 
type was very similar to that of GM-CSFdeficient mice 
(Dranoff et al., 1994; Stanley et al., 1994). GM-CSF is 
produced by many cell types present in the lungs, such as 
bronchial epithelial cells, macrophages, endothelial cells, 
and fibroblasts (Smith et al., 1990; Thorens et al., 1987; 
Seelentag et al., 1987; Zucali et al., 1987). Alveolar macro- 
phages are responsive to GM-CSF (Bilyk and Holt, 1993), 
and may play a role in lung homeostasis by clearing surfac- 
tant and other debris from alveolar spaces (Wright and 
Dobbs, 1991). It is possible that alveolar macrophages 
could not function normally without GM-CSF, which led 
to the accumulation of material in the alveoli. In this sense, 
it was interesting that there were many alveolar macro- 
phages that contained PAS-positive material in the 27- 
week-old pc mutants. This suggests that phagocytosis was 
occurring but subsequent degradation of this material may 
not have occurred effectively. Transfer of 8c mutant bone 
marrow cells has not resulted in obvious lung pathology 
in recipient animals. This may be due either to the involve- 
ment of nonhematopoietic cells in the disease, or to ineffi- 
cient repopulation in lung tissue by hematopoietic cells. 
The etiology of the peribronchovascular lymphocytic in- 
filtration is not known. This pathology was also found in 
GM-CSF-deficient mice (Dranoff et al., 1994; Stanley et 
al., 1994), in which both B and T cells (B220+, CD4+, and 
CD8+ cells) accumulated. It has been reported that alveo- 
lar macrophages inhibited proliferation of lymphocytes, 
and that lymphocyte infiltration around blood vessels was 
observed after treatment of mice with liposomes con- 
taining adrug cytotoxicfor alveolar macrophages and sub 
sequent immunization (Bilyk and Holt, 1993; Thepen et 
al., 1989). One interpretation is that alveolar macrophages 
play a role in down-regulating lymphocytic infiltration. As 
suggested by Dranoff et al. (1994), the continual exposure 
of lungs to inhaled antigens may require a dampening of 
inappropriate immune responses, and this process may 
be regulated by GM-CSF signals through the 8c receptor 
on alveolar macrophages. 
Routine and extensive screening of mutant and control 
animals revealed the absence of specific pathogens. Com- 
parisons of the severity of lung pathology between the 8c 
mutants described here and GM-CSFdeficient mice may 
be as reflective of animal room conditions as genetic pre- 
disposition. Nevertheless, the basic observations between 
these mice are in good agreement, and suggest the possi- 
ble clinical use of GM-CSF for some types of lung disease. 
Eosinophilia is observed in a variety of clinical settings, 
such as parasite infections, asthma, allergic respiratory 
disease, hypereosinophilic syndrome, and eosinophilia- 
myalgia syndrome. IL-3, GM-CSF, and IL-5 have been 
shown to stimulate eosinophils in vitro. Unlike IL-3 and 
GM-CSF, IL-5 appears to affect the more mature eosino- 
phil lineage (Yamaguchi et al., 1988a, 1988b). 
The lower number of basal level peripheral eosinophils 
in 8c-deficient mice could be attributed to the lack of IL-5 
signaling, as this phenotype was not observed in GM-CSF- 
deficient mice. This leads to the suggestion that IL-5 is 
important for maintaining basal levels of eosinophils in 
steady-state hematopoiesis, perhaps produced from acti- 
vated T cells. Although eosinophils were greatly reduced 
in 8c mutants, the few remaining eosinophils were mor- 
phologically normal. The in vitro CFU assays indicated 
that IL-3 stimulation could produce eosinophils from 8c 
mutant cells. Collectively, these data indicate that factors 
other than IL-5 may be capable of generating eosinophils 
to some extent, but that IL-5 is of primary importance 
in vivo. 
N. brasiliensis is a nematode parasite that has been 
widely used as a model in studying host immunity. The 
third-stage larvae of N. brasiliensis typically infect an ani- 
mal by penetration through the skin, followed by migration 
to the lungs. Numerous studies have shown that the nor- 
mal response to N. brasiliensis is driven by a Th2 cell 
response: that is, strong production of IL-4 and IL-5. The 
resulting immune response includes blood and tissue eo- 
sinophilia and IgE production (for review see Urban et al., 
1992). 
The fact that 8c mutants lacked eosinophilia in response 
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Figure 7. Bone Marrow Transfer 
(A) The total number of peripheral leukocytes after bone marrow tfans- 
plantation. The data represent the mean ( f standard deviation) of 5 
mice in each group. Open circles indicate animals grafted with control 
donor cells and closed circles indicate animals grafted with f3c mutant 
donor cells, Three independent donors were used both for controls 
and 6c mutants, and consistent results were obtained. 
to parasitic infections indicated that the signal through 
PC, probably IL-5 was indispensable for evoking a normal 
immune response. Blood analysis from parasite-infected 
PC mutants, followed to 21 days postinfection, showed no 
detectable eosinophilia. Similar to the conclusions from 
the blood data, PC mutant lung tissue at day 14 postinfec- 
tion showed no eosinophils. These observations were con- 
sistent with a study using an anti-IL-5 antibody (Coffman et 
al., 1989). However, in contrast with the anti-IL-5 antibody 
study, these lungs showed signs of severe edematous 
fluid accumulation and massive infiltration of mononuclear 
cells and neutrophils without any granulomatous lesions, 
whereas clearly defined granulomatous lesions were 
formed in the controls. This additional pathologic condition 
may have been related to the preexisting lung pathology 
in the mutant animals, or due to the lack of the response 
to GM-CSF during the parasitic infection. Interestingly, at 
day 21 postinfection, the 3c mutants showed small granu- 
lomatous lesions with a disproportionately low number of 
eosinophils, whereas control animals had resolved the 
lung response at this timepoint. These data indicate that 
other signals, possibly IL-3 interacting through P,u, could 
recruit eosinophils to a much lesser extent and at much 
slower kinetics. The normal increase in serum IgE levels 
during the parasite response was consistent with other 
reports indicating that IgE was controlled by IL-4 (Finkel- 
manet al., 1988; Kuhnetal., 1991).Therefore, IL4produc 
tion must be normal during the parasite challenge, indicat- 
ing that the overall Th2 response is not likely to be affected 
in the pc mutant animals. As GM-CSF has been implicated 
in dendritic cell differentiation and function (Inaba et al., 
1992) it will be worthwhile to isolate this cell type and 
test them functionally despite the fact the IgE response 
induced by N. brasiliensis implies functional antigen pre- 
sentation. Despite the abnormalities described above, PC 
mutants survived the infections. The strain of N. bra- 
siliensis used in this study was adapted to rats and, thus, 
the parasites did not adhere to the intestinal walls of mice. 
This study, therefore, did not address the parasite burden. 
The bone marrow transfer experiment showed that PC 
mutant cells could not repopulate lethally irradiated recipi- 
ents as efficiently as the wild-type cells. Although unmani- 
(6) The percentage of peripheral eosinophils after bone marrow trans- 
plantation. The same mice from (A) were evaluated, and are repre- 
sented as in (A). 
Figure 6. Lung Pathology in Response to N. brasiliensis Challenge 
(A) Pulmonary tissue from the control mouse 14 days after infection of N. brasiliensis. Note the prominent peribronchoalveolar lymphocytic infiltration 
and scattered granulomatous lesions (65.5 x). Inset, prominent eosinophil infiltration and macrophages in granulomatous lesions (342 x). 
(6) Pulmonary tissue from the 6c mutant mouse 14 days after infection of N. brasiliensis. Note the infiltration of inflammatory ceils was not only 
in the peribronchial areas but also in most of the pulmonary airspace (65.5 x). Lower magnification (inset) showed an infiltration of inflammatory 
cells in the entire pulmonary lobe (265x). There were no granulomatous lesions in the specimen. 
(C)Pulmonary tissue from the control mouse 21 days after infection of N. brasiliensis. There were remnant infectious lesions where some mononuclear 
cells were seen (85.5 x). 
(D) Pulmonary tissue from the 6c mutant mouse 21 days after infection of N. brasilisnsis. Low magnification showed prolongation of inflammatory 
process with some small granulomatous lesions (65.5x). Inset, higher magnification of the granulomatous lesions where infiltration of eosinophils 
was occasionally observed (342 x) 
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pulated 5c mutant mice had normal leukocyte counts, ex- 
cept for eosinophils, signals through pc increased the 
kinetics of recovery during a hematopoietic crisis. How- 
ever, animals repopulated with pc mutant cells did not 
show an increase in mortality under our experimental con- 
ditions and eventually regained leukocyte counts compa- 
rable to animals repopulated by normal bone marrow. This 
is consistent with the therapeutic use of GM-CSF to enhance 
leukocyte recovery postchemotherapy, bone marrow trans- 
plantation, or both (Antman et al., 1988; Nemunaitis et al., 
1988). The percentage of peripheral eosinophils was also 
reduced in the animals grafted with DC-deficient deficient 
cells, and confirms the autonomous requirement for PC 
signaling on this cell type. 
IL-5 is an IgA-enhancing factor (Bond et al., 1987). 
Steady-state levels of serum IgA were examined in 9c mu- 
tant mice and found to be normal, as were IgM and IgGl 
levels (data not shown). Additionally, peritoneal Ly-1 (CD5) 
B cells, which were reported to express functional IL-5 
receptor complexes (Hitoshi et al., 1990) (Wetzel, 1989) 
were present in close to normal numbers. A tendency to- 
ward fewer of these cells was observed in pc mutants 
but, due to animal to animal variation, was not statistically 
significant (data not shown). 
To address the role of the entire IL3/GM-CSF/ILd sys- 
tem, it would be necessary to generate mice lacking both 
PC and PIU. This necessitates a double mutation in embry- 
onic stem cells, because these two genes are closely 
linked on chromosome 15, making intercrossing the two 
mutant mice impractical. 
The description of @z-deficient mice presented here sug- 
gests that these animals will be useful models for other 
studies of infectious diseases and recovery from hemato- 
poietic crisis. Owing to the complexities of cytokine bind- 
ing to common receptor molecules, comparisons of mu- 
tant mice for both cytokines and their receptors will 
ultimately allow for a full understanding of these molecules 
in vivo. 
Experimental Procedures 
Generation of fk and j%,,-Deficient Mice 
(.ic and pIu genomic DNA were cloned from a C57BU6N genomic 
library (Gorman et al., 1992). The targeting vectors for 5c and BIu were 
constructed by incorporating a 5.6 kb Smal-Smal fragment and a 6.3 
kb Bglll-Fspl fragment, respectively, which contain exon 2 to exon 6, 
into a vector that contained the neomycin-resistant (neo’) gene (PMC7- 
neo poly(A)+) and a herpes simplex virus thymidine kinase (HSV-tk) 
in tandem. The 5’ genomic fragment upstream of a Sac1 site in exon 4 
was subcloned into an Xhol site Sof neo’gene, and the 3’downstream 
fragment was cloned into a BamHl site 3’ of neo’ gene, resulting in 
an insertion of neo’ gene in the same transcriptional direction as that 
of PC and 5,~1. The constructs were linealized by Clal and used to 
electroporate El4.1 cells. The cells were plated on mitomycin 
C-treated primary embryonic fibroblasts. and clones resistant to 6416 
(350 rig/ml) and gancyclovir (GANC) (2 PM) were screened by polymer- 
ase chain reaction (PCR) and Southern blot analysis. Pools of 6 clones 
were analyzed by PCR, using a 5’ primer in the coding region of the 
neo’ gene and a 3’ primer in exon 6 downstream of 3’ homology. 5’ 
primer: GCGTTGGCTACCCGTGATAT: 3’ primer: GGTCTCCCAGA- 
CAAGCTTGAACC. For Southern blot analysis, the genomic DNA from 
the PCR-positive clones was digested with BamHI, electrophoresed 
through 0.7% agarose gels, transferred to nylon membranes (Hybond 
N+. Amersham), and hybridized to a radioactive probe. The probe used 
to screen the samples was a Hindlll-BamHI 600 bp fragment of 61~3 
downstream of 3’ homology (probe D). The samples were also digested 
with EcoRI, Hindlll, or Bglll and hybridized with the other three probes 
(probes A, B, and C). A probe corresponding to the neo’ sequence 
(probe 6) was used to verify that only one copy of the vector was 
integrated into the genome. Df 1034 clones, 25 were correctly targeted 
for 6c, and 12 out of 471 were targeted for &. Recipient blastocysts 
were from C57BL16N mice. Chimeric animals were bred with C57BU 
6N females. All mutant animals studied were of the F2 generation. 
FACS Analyrir and Immunopreclpltatlon 
Anti-@-specific monoclonal antibody (gift from Dr. S. Yonehara) and 
9D3, an anti-51u-specific monoclonal antibody, were used for FACS 
analysis (Ogorochi et al., 1992). Both recognized the extracellular do- 
main of 3c and j3,=, respectively. 
Monoclonal antibody 3D1, which recognized the second extracellu- 
lar repeat of conserved cytokine receptor motif of Blu, was used for 
immunoprecipitation (Dgorochi et al., 1992). Affinity-purified rabbit an- 
tibody, which recognized the amino-terminal 1.5 aa of fkLl but not of 
6c, was used for immunoblotting (Mui et al., 1992). Rat lgG2 was used 
as an isotype control. 
lmmunoprecipitation and Western blotting were performed as de- 
scribed previously (Mui et al., 1992). In brief, 1 x IO’ bone marrow- 
derived mast cells were lysed and incubated with 10 pg of 3Dl or 
isotype control for 2 hr at 4OC. followed by incubation with anti-rat IgG 
agarose beads for 1 hr at 4OC. The samples were electrophoresed 
on 10% SDS-polyacrylamide gels and transferred to Immobilon-P 
membrane (Millipore). The blot was incubated with affinity-purified anti- 
j31u rabbit antibody and subsequently with horseradish peroxydase- 
conjugated anti-rabbit antibody. The development was performed by 
the enhanced chemiluminescence detection system (Amenham). 
Hematologlcal Analysis 
Total leukocyte, hemoglobin, and platelet estimates were performed 
on tail-bled samples using a System 9010 CP blood analyzer (Serono). 
Manual 500-cell leukocyte differential counts were performed on 
Wright-Giemsa-stained smears. Methyl cellulose colony assays were 
performed as described (Nakahata and Ogawa, 1962). The cells were 
stimulated by the following recombinant growth factors: murine IL-3 
(10 @ml), murine GM-CSF(lO @ml), murine IL-5(100 rig/ml), human 
erythropoietin (2 U/ml), human IL-6 (100 @ml), and mouse stem cell 
factor (100 @ml). 
Infection of N. braslllensls 
Mice (11 weeks old) were injected subcutaneously with 500 third-stage 
N. brasillensis larvae, as described (Urban et al., 1992). Animals were 
bled from the tail vein on the days indicated, and the eosinophils were 
counted by multiplying their percentage in smears by the total number 
of leukocytes. The data represent the mean ( f standard deviation) 
eosinophil counts per cubic millimeter in groups of 5 mice. Serum 
IgE was determined by an IgGspecific enzyme-linked immunosorbent 
assay (Coffman and Catty, 1966). 
Bone Marrow Transplantation 
Bone marrow cells (1 x IO? were injected intravenously into lethally 
irradiated (1300 rads) recipients. Bone marrow from three 6c mutant 
animals and from three control animals was separately transferred 
into between 5 and 9 irradiated recipient animals. 129/J (Ly 5.1) x 
C57BUSJL (Ly 5.2) Fl were used as hosts. The cells of hosts express 
Ly 5.1 and Ly5.2, while donorcells expressonly Ly5.1. FACS analysis 
of transplanted animals confirmed repopulation of donor cells. Cell 
sorting experiments were performed on a FACstar Plus (Becton Dickin- 
son) and gave 99% purity of the sorted populations. 
CFUS Assay 
Bone marrow cells were injected intravenously into lethally irradiated 
(1199 rads) C57BU6N recipients. Cells (Iv) and 5 x IO’ cells were 
used for day 6 CFU-S and day 12 CFU-S, respectively. 
Pathologlcal Examlnatlon 
Mice were fixed with 3% formaldehyde, and visceral organs were pro 
cessed for paraffin-embedded sectioning at 5 nm in thickness, followed 
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by double staining with hematoxylin and eosin. Complete serial sec- 
tioning was made for pulmonary tissues to ensure the degree and 
spread of each pulmonary lesion, and every third section was stained 
with PAS reaction to evaluate the possible deposition of mucopolysac- 
charides. 
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